ArticleEuropean heart journal. Case reports2026
Very late thrombosis of Amplatzer septal occluder device: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Device-related thrombosis is a rare but recognized complication following transcatheter atrial septal defect (ASD) closure, typically occurring within the first-year post-implantation. While early thrombus formation has been documented, very late presentations remain exceedingly uncommon. Case summary: We report a case of delayed device-associated thrombosis occurring 23 years after ASD closure with a 36 mm Amplatzer device. A 75-year-old female with multiple cardiovascular risk factors presented with acute left upper limb weakness, dysphagia, and slurred speech. Neuroimaging revealed infarcts in the right middle cerebral artery territory, consistent with an ischaemic stroke. Transthoracic echocardiography (TTE) identified a mass on the left atrial surface of the device. Transoesophageal echocardiography (TOE) confirmed a mobile thrombus on the right atrial surface and a sessile mass on the left atrial disc. There was no residual shunting. The patient was commenced on anticoagulation. Discussion: This case represents the most delayed instance of device-associated thrombosis reported to our knowledge. It highlights the diagnostic value of TOE when TTE is inconclusive and underscores the need for individualized anticoagulation strategies. Given the increasing use of transcatheter closure devices, this case raises important questions regarding the optimal duration of post-implantation surveillance, especially in elderly patients with comorbidities. A tailored follow-up approach may be warranted to mitigate late complications. Conclusion: Clinicians should maintain vigilance for device-associated thrombosis even decades after percutaneous ASD closure, particularly in patients with embolic phenomena. Extended surveillance imaging may be necessary in patients with significant comorbidities and risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.